Country: United States
Language: English
Source: NLM (National Library of Medicine)
KETOROLAC TROMETHAMINE (UNII: 4EVE5946BQ) (KETOROLAC - UNII:YZI5105V0L)
Allergan, Inc.
OPHTHALMIC
PRESCRIPTION DRUG
ACULAR ® ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. ACULAR ® ophthalmic solution is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction. ACULAR ® solution is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation. Teratogenic Effects. Pregnancy Category C Ketorolac tromethamine, administered during organogenesis, was not teratogenic in rabbits and rats at oral doses of 3.6 mg/kg/day and 10 mg/kg/day, respectively. These doses are approximately 100 times and 250 times higher respectively than the maximum recommended human topical ophthalmic daily dose of 2 mg (5 mg/mL x 0.05 mL/drop, x 4 drops x 2 eyes) to affected eyes on a mg/kg basis. Additionally, when administered to rats after Day 17 of gestation at oral doses up to 1.5 mg/kg/day (approximately 40 times the typical human topical ophthalmic daily dos
ACULAR ® (ketorolac tromethamine ophthalmic solution) 0.5% is supplied sterile, in white opaque plastic LDPE bottles with white droppers, with gray high impact polystyrene (HIPS) caps as follows: 5 mL in 10 mL bottle NDC 0023-2181-05 Storage: Store at 15°-25°C (59°-77°F). Protect from light.
New Drug Application
ACULAR- KETOROLAC TROMETHAMINE SOLUTION/ DROPS ALLERGAN, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE ACULAR SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ACULAR . ACULAR (KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION) 0.5% INITIAL U.S. APPROVAL: 1991 INDICATIONS AND USAGE ACULAR ophthalmic solution is a nonsteroidal, anti-inflammatory indicated for: The treatment of inflammation following cataract surgery. (1) The temporary relief of ocular itching due to seasonal allergic conjunctivitis. (1) DOSAGE AND ADMINISTRATION One drop of ACULAR should be applied to the affected eye(s) four times a day for relief of ocular itching due to seasonal allergic conjunctivitis. For the treatment of postoperative inflammation in patients who have undergone cataract extraction, one drop of ACULAR should be applied to the affected eye four times daily beginning 24 hours after cataract surgery and continuing through the first 2 weeks of the postoperative period. (2.1) DOSAGE FORMS AND STRENGTHS Ophthalmic solution containing 5 mg/mL ketorolac tromethamine. (3) 10 mL size bottle filled with 5 mL of solution CONTRAINDICATIONS Hypersensitivity to any component of this product. (4) WARNINGS AND PRECAUTIONS Delayed healing (5.1) Cross-sensitivity or hypersensitivity (5.2) Increased bleeding time due to interference with thrombocyte aggregation (5.3) Corneal effects including keratitis (5.4) ADVERSE REACTIONS The most frequent adverse reactions reported by up to 40% of patients participating in clinical trials have been transient stinging and burning on instillation. (6.1) TO REPORT SUSPECTED ADVERSE REACTIONS, CONTACT ALLERGAN AT 1-800-433-8871 OR FDA AT 1-800-FDA-1088 OR WWW.FDA.GOV/MEDWATCH. SEE 17 FOR PATIENT COUNSELING INFORMATION. REVISED: 12/2011 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosing 2.2 Use with Other Topical Ophthalmic Medications 3 DOSAGE FORMS AND STRENGTHS 4 CONTRA Read the complete document